4.3 Review

Can GH-therapy worsen a clinically silent Chiari malformation? A case report and systematic literature review.

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document

Palma Ciaramitaro et al.

Summary: This study aimed to reach a consensus among international experts on controversial issues in the diagnosis and treatment of Chiari 1 malformation and syringomyelia in adults. Through a multidisciplinary panel, a Delphi process, and face-to-face discussions, a consensus was reached on 57 out of 63 statements related to the conditions. The consensus document, consisting of 63 statements, was the result of expert discussion and serves as a guide for clinicians and researchers following adults with Chiari and syringomyelia.

NEUROLOGICAL SCIENCES (2022)

Article Endocrinology & Metabolism

Mosaic Turner syndrome with improved Chiari type 1 malformation after growth hormone therapy: A case report

Toshihiko Mori et al.

Summary: A three-year-old girl with mosaic Turner syndrome and Chiari type 1 malformation showed disappearance of the malformation after growth hormone therapy. GH therapy can exacerbate or ameliorate Chiari type 1 malformations, especially in cases where Turner syndrome requires higher GH levels. Close monitoring is necessary for cases where the disease is associated with Chiari type 1 malformation.

CLINICAL PEDIATRIC ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study

Lars Savendahl et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Article Clinical Neurology

Chiari I-a 'not so' congenital malformation?

Dominic N. P. Thompson

CHILDS NERVOUS SYSTEM (2019)

Article Health Care Sciences & Services

CARE guidelines for case reports: explanation and elaboration document

David S. Riley et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)

Article Endocrinology & Metabolism

Diagnosis of growth hormone deficiency in the paediatric and transitional age

A. Chinoy et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Clinical Neurology

Prevalence of Chiari I Malformation and Syringomyelia

Elyne N. Kahn et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2015)

Article Clinical Neurology

Progression of Chiari I malformations while on growth hormone replacement: a report of two cases

Robert P. Naftel et al.

CHILDS NERVOUS SYSTEM (2013)

Article Pediatrics

Clinical Heterogeneity in two patients with Noonan-like Syndrome associated with the same SHOC2 mutation

Donatella Capalbo et al.

ITALIAN JOURNAL OF PEDIATRICS (2013)

Article Clinical Neurology

Institutional experience with 500 cases of surgically treated pediatric Chiari malformation Type I Clinical article

R. Shane Tubbs et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2011)

Editorial Material Pediatrics

Symptomatic Chiari 1 Malformation after Initiation of Growth Hormone Therapy

Michael J. O'Grady et al.

JOURNAL OF PEDIATRICS (2011)

Article Endocrinology & Metabolism

Analysis of Craniofacial and Extremity Growth in Patients with Growth Hormone Deficiency during Growth Hormone Therapy

Maria Estela Justamante de Faria et al.

HORMONE RESEARCH (2009)

Article Clinical Neurology

Resolution of syringomyelia and Chiari malformation after growth hormone therapy

Ashok Gupta et al.

CHILDS NERVOUS SYSTEM (2008)

Letter Endocrinology & Metabolism

Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene

Lorenzo Iughetti et al.

CLINICAL ENDOCRINOLOGY (2008)

Article Clinical Neurology

Chiari I malformation and idiopathic growth hormone deficiency in siblings: report of three cases

R. Lee Murphy et al.

CHILDS NERVOUS SYSTEM (2007)

Article Endocrinology & Metabolism

Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

E. Cacciari et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)